Atrial Fibrillation 2026: Practical Updates Every Internist Needs to Know - Guidelines, Evidence and Practice (2026 CCHM)
Learning Objectives:
- Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation.
- Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation.
- Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.
Chad A. Link, DO, FACC, FACOI
Cardiologist
University of Michigan Health- Sparrow
Chad A. Link, D.O. FACC, FACOI received his medical degree from Michigan State University’s College of Osteopathic Medicine in East Lansing, Michigan. He completed both his Internal Medicine Residency and Cardiology Fellowship at Ingham Regional Medical Center in Lansing, Michigan. He is board certified in Internal Medicine, Cardiology and Nuclear Cardiology and serves as the cardiology chairman for the University of Michigan Health System-Sparrow Eaton and Ionia Hospitals and is a clinical assistant professor for the cardiology course at Michigan State University’s College of Osteopathic Medicine.
He specializes in cardiovascular medicine with the University of Michigan Health-Sparrow. Dr. Link’s background includes all aspects of clinical cardiology with specialized interest in the management of coronary artery disease, hyperlipidemia, echocardiography; nuclear cardiology and pulmonary hypertension. Professional memberships include: the American Society of Echocardiography, the American College of Cardiology, and the American Society of Nuclear Cardiology.
The faculty member, for this activity, has disclosed the following financial relationships:
- Astra Zeneca-Consulting Fees-Ongoing
- Johnson and Johnson-Consulting Fees-Ongoing
- Kiniska-Consulting Fees-Ongoing
Key:
Complete
Next
Failed
Available
Locked